search
Back to results

Cardiovascular Rehabilitation in Patients With Severe Aortic Stenosis Submitted to Valvar Correction (CARE-AS-MOTION)

Primary Purpose

Aortic Valve Stenosis

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
cardiovascular rehabilitation program
Sponsored by
Irmandade Santa Casa de Misericórdia de Porto Alegre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Aortic Valve Stenosis focused on measuring aortic stenosis, aortic valve replacement, transcatheter aortic valve implantation, frailty, cardiac rehabilitation

Eligibility Criteria

40 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: patients NYHA class II-IV who has not participated in a CRP three months before recruitment; older than 40 years; of both genders; with degenerative AS and indication for valve repair. The patients will not know which protocol to undergo.

Exclusion Criteria: patients with low cognitive level to perform the assessment or intervention procedures; that exhibit unstable angina or any contraindications for the treatment or measurements; as well musculoskeletal, cerebrovascular, or psychiatric disease that prevents their participation in the research.

Sites / Locations

  • Marlus Karsten

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

aortic valve replacement

transcatheter aortic valve implantation

Arm Description

patients with aortic stenosis submitted to aortic valve replacement procedure

patients with aortic stenosis who underwent to transcatheter aortic valve implantation

Outcomes

Primary Outcome Measures

Cardiorespiratory function
Peak oxygen consumption (VO2PEAK), among other physiologic markers.

Secondary Outcome Measures

Autonomic function
will be evaluated by heart rate variability using a wrist heart rate monitor following the recommendations of ESC/NASPE Task Force.
Endothelial function
will be investigated by endothelium-dependent flow-mediated vasodilation (FMD) technique following the International Brachial Artery Reactivity Task Force.
Hemodynamic function
will be evaluated the cardiac output using a cardiothoracic impedance device (noninvasive approach).
Inflammatory profile
Plasma levels will be determined by enzyme-linked immunosorbent assay using commercial systems.
Inspiratory muscle strength
Will be assessed as maximum inspiratory pressure (MIP) using a digital device following recommendations of the American Thoracic Society and European Respiratory Society.
Muscle architecture (peripheral muscles)
Will be evaluated the muscle thickness (cross-sectional area) of quadriceps using a ultrasonography system.
Muscle architecture (respiratory muscles)
Will be evaluated the diaphragm thickness (cross-sectional area) of quadriceps using a ultrasonography system.
Tissue oxygenation
near-infrared spectroscopy (NIRS) will be used to verify muscle oxygenation (quadriceps and respiratory muscles).
Functional capacity
The patients under favorable clinical conditions will be functionally evaluated by the Six-Minute Walk Test (6MWT) according to current guidelines.
Mortality
to evaluate the survival rate of the patients

Full Information

First Posted
May 21, 2015
Last Updated
May 13, 2020
Sponsor
Irmandade Santa Casa de Misericórdia de Porto Alegre
Collaborators
Federal University of Health Science of Porto Alegre
search

1. Study Identification

Unique Protocol Identification Number
NCT02468219
Brief Title
Cardiovascular Rehabilitation in Patients With Severe Aortic Stenosis Submitted to Valvar Correction
Acronym
CARE-AS-MOTION
Official Title
Cardiovascular RehAbilitation in Patients With Severe AoRtic StEnosis Submitted to Valvar Correction: Effects on Muscle Architecture, Tissue Oxygenation, EndoThelial Function, Inflammatory Profile, and AutoNomic Control - Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Unknown status
Study Start Date
August 2020 (Anticipated)
Primary Completion Date
July 2021 (Anticipated)
Study Completion Date
July 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Irmandade Santa Casa de Misericórdia de Porto Alegre
Collaborators
Federal University of Health Science of Porto Alegre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will be evaluate the autonomic, endothelial and hemodynamic functions, inspiratory muscle strength, peripheral tissue oxygenation, peripheral and respiratory muscle architecture, and inflammatory profile of severe AS patients submitted undergoing to valve replacement (sAVR) or transcatheter aortic valve implantation (TAVI), and their influence on the pathophysiological mechanisms involved in cardiovascular rehabilitation.
Detailed Description
Background: Aortic stenosis (AS) is a disease characterized by the inadequate valve opening, compromising the cardiac output. Surgical aortic valve replacement (sAVR) is the procedure indicates for valve repair in AS symptomatic cases whereas the transcatheter aortic valve implantation (TAVI) is the procedure indicates for sAVR contraindicated cases. Objective: To evaluate the effect of the cardiac rehabilitation program (pre-procedure, early post-procedure, and late post-procedure) in autonomic, endothelial and hemodynamic functions, inspiratory muscle strength, peripheral tissue oxygenation, peripheral and respiratory muscle architecture, and inflammatory profile of severe AS patients submitted to a valve repair procedure (sAVR or TAVI). Methods: The present study will be a randomized double-blind clinical trial in patients indicated to valve repair procedure. This research will be divided into four phases: phase 1 (pre-procedure); phase 2 (early post-procedure); phase 3 (late post-procedure) and phase 4 (follow-up). Phase 1: participants will be randomized in PR-I (pre-intervention) or PR-C (control). Pre-procedure rehabilitation program will consist of daily neuromuscular electrical stimulation (NMES) in knee extensor muscles and inspiratory muscle training (IMT) sessions. PR-C group will receive daily visits, but with a NMES + IMT protocols using a minimal load. Phase 2: a new random will be done between ER-II or ER-CI (intervention) and ER-IC or ER-CC (control). Intervention groups will undertake an early post-procedure rehabilitation (NMES in knee extensor muscle plus IMT for six weeks). Control groups will receive the same protocol using a minimal load without load progression. Phase 3: all patients will be referred to the conventional cardiac rehabilitation program (aerobic and resistance training) for 8-weeks. Phase 4: follow-up (no interventions), will be done after 3, 6, 9 and 12 months. Assessment protocol will be composed by cardiopulmonary exercise test, autonomic (heart rate variability), endothelial (flow-mediated vasodilation), hemodynamic function (cardiothoracic impedance) functional capacity (six-minute walk test), maximum inspiratory pressure, peripheral and respiratory muscle architecture (ultrasonography), and tissue oxygenation (near-infrared spectroscopy), and inflammatory profile (OxLDL, TGF-β, TNF-α, IL-1b, IL-10 and ICAM-1) Appropriate statistic tests will be used to compare the time-rehabilitation (experimental vs sham) and group-interaction (sAVR vs TAVI). If samples are abandoned or lost, basal data will be double entered to characterize the intention-to-treat analysis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Valve Stenosis
Keywords
aortic stenosis, aortic valve replacement, transcatheter aortic valve implantation, frailty, cardiac rehabilitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study will be divided into four phases: phase 1 (pre-procedure rehabilitation); phase 2 (early post-procedure rehabilitation); phase 3 (late post-procedure rehabilitation), and phase 4 (follow-up).
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
aortic valve replacement
Arm Type
Active Comparator
Arm Description
patients with aortic stenosis submitted to aortic valve replacement procedure
Arm Title
transcatheter aortic valve implantation
Arm Type
Experimental
Arm Description
patients with aortic stenosis who underwent to transcatheter aortic valve implantation
Intervention Type
Behavioral
Intervention Name(s)
cardiovascular rehabilitation program
Intervention Description
Phase I: 2-weeks of respiratory muscle training and neuromuscular electrical stimulation (daily at hospital). Phase II: 6-weeks of respiratory muscle training and neuromuscular electrical stimulation (daily at home). Phase III: 8-weeks of supervised, structured, combined aerobic and resistance training.
Primary Outcome Measure Information:
Title
Cardiorespiratory function
Description
Peak oxygen consumption (VO2PEAK), among other physiologic markers.
Time Frame
Changes from 8 and 16 weeks
Secondary Outcome Measure Information:
Title
Autonomic function
Description
will be evaluated by heart rate variability using a wrist heart rate monitor following the recommendations of ESC/NASPE Task Force.
Time Frame
Change from 2, 8 and 16 weeks
Title
Endothelial function
Description
will be investigated by endothelium-dependent flow-mediated vasodilation (FMD) technique following the International Brachial Artery Reactivity Task Force.
Time Frame
Changes from 2, 8 and 16 weeks
Title
Hemodynamic function
Description
will be evaluated the cardiac output using a cardiothoracic impedance device (noninvasive approach).
Time Frame
Changes from 2, 8 and 16 weeks
Title
Inflammatory profile
Description
Plasma levels will be determined by enzyme-linked immunosorbent assay using commercial systems.
Time Frame
Changes from 2, 8 and 16 weeks
Title
Inspiratory muscle strength
Description
Will be assessed as maximum inspiratory pressure (MIP) using a digital device following recommendations of the American Thoracic Society and European Respiratory Society.
Time Frame
Changes from 2, 8 and 16 weeks
Title
Muscle architecture (peripheral muscles)
Description
Will be evaluated the muscle thickness (cross-sectional area) of quadriceps using a ultrasonography system.
Time Frame
Changes from 8 and 16 weeks
Title
Muscle architecture (respiratory muscles)
Description
Will be evaluated the diaphragm thickness (cross-sectional area) of quadriceps using a ultrasonography system.
Time Frame
Changes from 8 and 16 weeks
Title
Tissue oxygenation
Description
near-infrared spectroscopy (NIRS) will be used to verify muscle oxygenation (quadriceps and respiratory muscles).
Time Frame
Changes from 2, 8 and 16 weeks
Title
Functional capacity
Description
The patients under favorable clinical conditions will be functionally evaluated by the Six-Minute Walk Test (6MWT) according to current guidelines.
Time Frame
Changes from 8 and 16 weeks
Title
Mortality
Description
to evaluate the survival rate of the patients
Time Frame
Change from 3, 6 and 12 months post protocol

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients NYHA class II-IV who has not participated in a CRP three months before recruitment; older than 40 years; of both genders; with degenerative AS and indication for valve repair. The patients will not know which protocol to undergo. Exclusion Criteria: patients with low cognitive level to perform the assessment or intervention procedures; that exhibit unstable angina or any contraindications for the treatment or measurements; as well musculoskeletal, cerebrovascular, or psychiatric disease that prevents their participation in the research.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marlus Karsten, PhD
Phone
55 51 33038876
Email
mkarsten@ufcspa.edu.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marlus Karsten, PhD
Organizational Affiliation
Federal University of Health Science of Porto Alegre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Marlus Karsten
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90050-170
Country
Brazil
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marlus Karsten, PhD
Phone
+55 51 33038876
Email
mkarsten@ufcspa.edu.br
First Name & Middle Initial & Last Name & Degree
Gustavo S Ribeiro
Phone
+55 51 99848530
Email
gustavosr@ufcspa.edu.br

12. IPD Sharing Statement

Citations:
PubMed Identifier
24631801
Citation
Montemezzo D, Fregonezi GA, Pereira DA, Britto RR, Reid WD. Influence of inspiratory muscle weakness on inspiratory muscle training responses in chronic heart failure patients: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014 Jul;95(7):1398-407. doi: 10.1016/j.apmr.2014.02.022. Epub 2014 Mar 13.
Results Reference
background
PubMed Identifier
23757283
Citation
Russo N, Compostella L, Tarantini G, Setzu T, Napodano M, Bottio T, D'Onofrio A, Isabella G, Gerosa G, Iliceto S, Bellotto F. Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. Eur J Prev Cardiol. 2014 Nov;21(11):1341-8. doi: 10.1177/2047487313494029. Epub 2013 Jun 11.
Results Reference
background
PubMed Identifier
24577878
Citation
Voller H, Salzwedel A, Nitardy A, Buhlert H, Treszl A, Wegscheider K. Effect of cardiac rehabilitation on functional and emotional status in patients after transcatheter aortic-valve implantation. Eur J Prev Cardiol. 2015 May;22(5):568-74. doi: 10.1177/2047487314526072. Epub 2014 Feb 27.
Results Reference
background
PubMed Identifier
24713461
Citation
Fauchere I, Weber D, Maier W, Altwegg L, Luscher TF, Grunenfelder J, Nowak A, Tuller D, Genoni M, Falk V, Hermann M. Rehabilitation after TAVI compared to surgical aortic valve replacement. Int J Cardiol. 2014 May 15;173(3):564-6. doi: 10.1016/j.ijcard.2014.03.121. Epub 2014 Mar 21. No abstract available.
Results Reference
background
PubMed Identifier
20560163
Citation
Sbruzzi G, Ribeiro RA, Schaan BD, Signori LU, Silva AM, Irigoyen MC, Plentz RD. Functional electrical stimulation in the treatment of patients with chronic heart failure: a meta-analysis of randomized controlled trials. Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):254-60. doi: 10.1097/HJR.0b013e328339b5a2.
Results Reference
background

Learn more about this trial

Cardiovascular Rehabilitation in Patients With Severe Aortic Stenosis Submitted to Valvar Correction

We'll reach out to this number within 24 hrs